PP
CELG

Paloma Partners’s Celgene Corp CELG Stock Holding History

Paloma Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,400
Closed -$667K – 2117
2018
Q4 		$667K Buy
+10,400
New +$768K 0.02% 580
2018
Q1 		– Sell
-19,600
Closed -$2.04M – 2457
2017
Q4 		$2.04M Hold
19,600
– – 0.03% 656
2017
Q3 		$2.86M Sell
19,600
-46,200
-70% -$6.29M 0.04% 528
2017
Q2 		$8.54M Buy
65,800
+6,400
+11% +$784K 0.1% 175
2017
Q1 		$7.39M Buy
59,400
+17,400
+41% +$2.08M 0.09% 180
2016
Q4 		$4.86M Buy
42,000
+18,000
+75% +$2M 0.05% 261
2016
Q3 		$2.51M Hold
24,000
– – 0.03% 441
2016
Q2 		$2.37M Buy
24,000
+16,800
+233% +$1.74M 0.03% 629
2016
Q1 		$721K Hold
7,200
– – 0.01% 1097
2015
Q4 		$862K Hold
7,200
– – 0.02% 727
2015
Q3 		$779K Sell
7,200
-82,800
-92% -$10.3M 0.02% 791
2015
Q2 		$10.4M Buy
+90,000
New +$10.3M 0.2% 103

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Paloma Partners's CELG Position: Q4 2019 in Review

Paloma Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 69,900 shares — an estimated $6.94M sold.

Paloma Partners first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $14.7M in Q1 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Paloma Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Paloma Partners sold 69,900 Celgene Corp shares in Q4 2019, an estimated $6.94M.
  • Paloma Partners first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Paloma Partners's Celgene Corp position peaked at $14.7M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.